BioAge Labs (BIOA) Other financing activities (2024 - 2026)

BioAge Labs has disclosed Other financing activities across 3 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Other financing activities changed N/A year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $3.9 million (down 98.15% YoY), while the FY2025 annual figure was $714000.0, down 99.66% from the prior year.
• Other financing activities came in at $1.5 million for Q2 2026 at BioAge Labs, down from $1.7 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $182.9 million in Q3 2024 to a low of $3000.0 in Q1 2024.
• Average Other financing activities over 3 years is $27.0 million, with a median of $1.4 million recorded in 2024.
• The largest YoY upside for Other financing activities was 97.57% in 2025 against a maximum downside of 99.98% in 2025.
• Over 3 years, Other financing activities stood at $27.6 million in 2024, then plunged by 97.57% to $670000.0 in 2025, then jumped by 119.85% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $1.5 million in Q2 2026, $1.7 million in Q1 2026, and $670000.0 in Q4 2025.